Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction
- PMID: 18467664
- DOI: 10.1634/stemcells.2007-0724
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction
Abstract
Although advances have been made in understanding the role of hypoxia in the stem cell niche, almost nothing is known about a potentially similar role of hypoxia in maintaining the tumor stem cell (TSC) niche. Here we show that a highly tumorigenic fraction of side population (SP) cells is localized in the hypoxic zones of solid tumors in vivo. We first identified a highly migratory, invasive, and tumorigenic fraction of post-hypoxic side population cells (SPm([hox]) fraction) in a diverse group of solid tumor cell lines, including neuroblastoma, rhabdomyosarcoma, and small-cell lung carcinoma. To identify the SPm((hox)) fraction, we used an "injured conditioned medium" derived from bone marrow stromal cells treated with hypoxia and oxidative stress. We found that a highly tumorigenic SP fraction migrates to the injured conditioned medium in a Boyden chamber. We show that as few as 100 SPm((hox)) cells form rapidly growing tumors in vivo. In vitro exposure to hypoxia increases the SPm((hox)) fraction significantly. Quantitative real-time polymerase chain reaction and immunofluorescence studies showed that SPm((hox)) cells expressed Oct-4, a "stemness" gene having a potential role in TSC maintenance. In nude mice xenografts, SPm((hox)) cells were localized to the hypoxic zones, as demonstrated after quantum dot labeling. These results suggest that a highly tumorigenic SP fraction migrates to the area of hypoxia; this migration is similar to the migration of normal bone marrow SP fraction to the area of injury/hypoxia. Furthermore, the hypoxic microenvironment may serve as a niche for the highly tumorigenic fraction of SP cells.
Similar articles
-
Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense.Front Immunol. 2022 Sep 29;13:933329. doi: 10.3389/fimmu.2022.933329. eCollection 2022. Front Immunol. 2022. PMID: 36248858 Free PMC article.
-
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling.Oncogene. 2008 Jun 26;27(28):3923-34. doi: 10.1038/onc.2008.38. Epub 2008 Mar 10. Oncogene. 2008. PMID: 18332870
-
Identification of neuroblastoma stem cells by characterization of side population cells in the human neuroblastoma SK-N-SH cell line.J Pediatr Surg. 2010 Dec;45(12):2305-11. doi: 10.1016/j.jpedsurg.2010.08.022. J Pediatr Surg. 2010. PMID: 21129535
-
Laboratory models for central nervous system tumor stem cell research.Adv Exp Med Biol. 2015;853:69-83. doi: 10.1007/978-3-319-16537-0_5. Adv Exp Med Biol. 2015. PMID: 25895708 Review.
-
Hypoxic tumor microenvironment and cancer cell differentiation.Curr Mol Med. 2009 May;9(4):425-34. doi: 10.2174/156652409788167113. Curr Mol Med. 2009. PMID: 19519400 Free PMC article. Review.
Cited by
-
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359. BMC Cancer. 2012. PMID: 22901285 Free PMC article.
-
Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells.Stem Cell Res Ther. 2022 May 3;13(1):181. doi: 10.1186/s13287-022-02856-6. Stem Cell Res Ther. 2022. PMID: 35505363 Free PMC article. Review.
-
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.Mol Cancer. 2010 Oct 27;9:283. doi: 10.1186/1476-4598-9-283. Mol Cancer. 2010. PMID: 20979610 Free PMC article.
-
Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.Mol Aspects Med. 2014 Oct;39:3-32. doi: 10.1016/j.mam.2013.08.001. Epub 2013 Aug 29. Mol Aspects Med. 2014. PMID: 23994756 Free PMC article. Review.
-
ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.Cancer Sci. 2016 Apr;107(4):433-43. doi: 10.1111/cas.12895. Epub 2016 Mar 16. Cancer Sci. 2016. PMID: 26800504 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources